cancer

envie a um amigo share this

First International Symposium on the Impact of Occupational Exposures on DNA Stability and Human Cancer Risks

HSZ Hörsaalzentrum der Medizinischen Universität Graz, Graz, Austria

 

12 September 2015

 

See more informations here: http://www.eacr.org/user_uploads/files/meetings/Graz%2012-9-2015.pdf

First International Symposium on the Impact of Occupational Exposures on DNA Stability and Human Cancer Risks

HSZ Hörsaalzentrum der Medizinischen Universität Graz, Graz, Austria

 

12 September 2015

 

See more informations here: http://www.eacr.org/user_uploads/files/meetings/Graz%2012-9-2015.pdf

Molecule patented by the University of Coimbra for innovative therapy in the treatment of several types of cancer reveals efficacy

Authors and Affiliations:

Luis B. Rochaa, Lígia C. Gomes-da-Silvab, Janusz M. Dąbrowskic, Luis G. Arnauta,b

a Luzitin SA, R. Bayer, S. Martinho do Bispo, 3045-016 Coimbra, Portugal

b Chemistry Department, University of Coimbra, 3004-535 Coimbra, Portugal

c Faculty of Chemistry, Jagiellonian University, 30-060 Kraków, Poland

 

Abstract:

Molécula patenteada pela Universidade de Coimbra para terapia inovadora no tratamento de vários tipos de cancro revela a eficácia desejada

Vários estudos e experiências realizadas em ratinhos, entre 2011 e 2014, provaram a eficácia da molécula Redaporfin, descoberta na Universidade de Coimbra (UC) para o tratamento de vários tipos de cancro através de terapia fotodinâmica, uma terapia inovadora que permite eliminar as células cancerígenas de forma precisa.

Overexpression of pyruvate dehydrogenase kinase supports DCA as a candidate for cutaneous melanoma therapy

DCA was proposed as a possible cancer therapy, although it was unknown its possible use as cutaneous melanoma therapy. A team of IPATIMUP researchers published a study in Expert Opinion on Therapeutic Targets, where they evaluated the expression profile of pyruvate dehydrogenase kinase isoforms, the DCA targets, in a series of melanoma samples and nevi, and also established the sensitivity of melanoma cell lines to DCA treatment.

Oncology Meets Immunology

Hotel Crowne Plaza, Athens, Greece

 

12- 13 June, 2015

 

See more informations here: http://www.eacr.org/user_uploads/files/meetings/SAVE%20THE%20DATE%20IMMUNOLOGY%208.pdf

Oncology Meets Immunology

Hotel Crowne Plaza, Athens, Greece

 

12- 13 June, 2015

 

See more informations here: http://www.eacr.org/user_uploads/files/meetings/SAVE%20THE%20DATE%20IMMUNOLOGY%208.pdf

5th Munich Biomarker Conference

RAMADA Hotel & Conference Center Messe München, Munich, Germany

 

1-2 December, 2015

 

See more informations here: http://www.bio-m.org/mbc/5th-munich-biomarker-conference.html

SFC Basic Science Day: Genome instability and cancer new ideas

Institut Curie, Amphithéâtre Constant Burg, Paris, France

 

19 June 2015

 

See more informations here: http://sfc.asso.fr/home/53-basic-science.html

SFC Basic Science Day: Genome instability and cancer new ideas

Institut Curie, Amphithéâtre Constant Burg, Paris, France

 

19 June 2015

 

See more informations here: http://sfc.asso.fr/home/53-basic-science.html